Similarly, in a rat model of high fructose-induced steatohepatitis, nicotinamide mitigates liver steatosis and fibrosis by regulating redox homeostasis through a G6PD-dependent mechanism (52). The gene discussed is G6PD; the disease is fatty liver disease.